Scoring microvascular invasion in hepatocellular carcinoma:are we meeting the grade?  

作　　者：Derek J.Erstad Kenneth K.Tanabe 

机构地区：[1]Division of Surgical Oncology,Baylor College of Medicine,Houston,TX,USA [2]Division of Gastrointestinal and Oncologic Surgery,Harvard Medical School and Massachusetts General Hospital,Boston,MA,USA

出　　处：《Hepatobiliary Surgery and Nutrition》2024年第1期184-187,共4页肝胆外科与营养（英文）

摘　　要：Hepatocellular carcinoma(HCC)is the second leading cause of cancer-related mortality and has rising global incidence(1).A perplexing aspect of this disease is the high rate of recurrence(50-70%)after curative-intent,margin negative surgical resection(2).While de novo HCC arising from baseline chronic liver injury is a driver of late recurrences,most recurrences occur over a short interval and are thought to be spread from the index malignancy.

关 键 词：Microvascular invasion(MVI) hepatocellular carcinoma(HCC) HEPATECTOMY 

分 类 号：R735.7[医药卫生—肿瘤]